Monoclonal antibody provides strong real-world protection against severe RSV in infants, suggests meta-analysis
Nirsevimab, a monoclonal antibody, is highly effective in real-world conditions at preventing severe respiratory syncytial virus (RSV) infections in infants, suggests a meta-analysis published in The Lancet Child & Adolescent ...
May 1, 2025
0
11